The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
Abstract
Although vasodilator therapy has been shown to improve functional capacity in patients with congestive heart failure, there is no evidence that such therapy can prolong survival. Coronary artery ligation in the rat was used to produce a wide range of myocardial infarct sizes and a resultant spectrum of left ventricular dysfunction. To determine the relationship between size of myocardial infarction and long-term survival and to test the hypothesis that long-term therapy with captopril could improve survival after myocardial infarction, 302 rats were randomly assigned to either placebo or captopril therapy 14 days after coronary artery ligation. The animals were kept in a laminar flow unit and followed daily for a 1 year period or until spontaneous death. Size of myocardial infarction was determined by planimetry of serial histologic sections of the left ventricle. One year survival in placebo-treated rats decreased markedly in direct relation to increasing size of infarction (from 71% in noninfarcted rats to only 8% in rats with large infarcts). Long-term captopril therapy prolonged the survival of rats with infarcts (p less than .02). The most marked improvement in survival was noted in the animals with infarcts of moderate size, in which 1 year survival was 21% in the placebo-treated rats and 48% in the captopril-treated rats. Thus, in this experimental preparation of myocardial infarction and left ventricular dysfunction, survival was inversely related to size of infarction. Long-term therapy with captopril, which we had previously shown to improve left ventricular function and lessen dilatation in the chronic phase of infarction, also had a pronounced effect on prolonging survival in this preparation of chronic infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Myocardial infarct size and ventricular function in rats.
Pfeffer, M. A., Pfeffer, J. M., Fishbein, M. C., Fletcher, P. J., Spadaro, J., Kloner, R. A., & Braunwald, E. (1979) · Circulation Research · doi:10.1161/01.res.44.4.503 · Cited by 1,281
Self-citationInfluence of chronic captopril therapy on the infarcted left ventricle of the rat.
Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1985) · Circulation Research · doi:10.1161/01.res.57.1.84 · Cited by 808
Self-citationFranciosa, J. A., Wilen, M., Ziesche, S., & Cohn, J. N. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80141-6 · Cited by 672
Wilson, J. R., Schwartz, J. S., St. John Sutton, M., Ferraro, N., Horowitz, L. N., Reichek, N., & Josephson, M. E. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80265-4 · Cited by 393
Dzau, V. J., Colucci, W. S., Williams, G. H., Curfman, G., Meggs, L., & Hollenberg, N. K. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006193022501 · Cited by 377
Epidemiology of congestive heart failure
Smith, W. M. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90789-1 · Cited by 372
Fletcher, P. J., Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1981) · Circulation Research · doi:10.1161/01.res.49.3.618 · Cited by 362
Self-citationGeltman, E. M., Ehsani, A. A., Campbell, M. K., Schechtman, K., Roberts, R., & Sobel, B. E. (1979) · Circulation · doi:10.1161/01.cir.60.4.805 · Cited by 318
Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism
Packer, M. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80230-7 · Cited by 124
Effect of vasodilators on survival in chronic congestive heart failure
Furberg, C. D., & Yusuf, S. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90756-8 · Cited by 119
Massie, B. M., Krämer, B., & Topic, N. (1984) · Circulation · doi:10.1161/01.cir.69.6.1135 · Cited by 113
Creager, M. A., Faxon, D. P., Halperin, J. L., Melidossian, C. D., McCabe, C. H., Schick, E. C., & Ryan, T. J. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90043-6 · Cited by 93
Cited by
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Self-citationEffects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Metadata
- Authors
- Pfeffer, M. A., Pfeffer, J. M., Steinberg, C., & Finn, P.
- Venue
- Circulation
- Published
- 1985-08
- Volume
- 72
- Issue
- 2
- Pages
- 406-412
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2003563752
- Cited by
- 718
- References
- 14
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.